“This does look more like a two-dose vaccine,” Dr. Michael Nelson, a temporary voting member of the FDA committee. The group of people who would qualify for the J&J booster can get it two months after getting their first dose.
The Food and Drug Administration should authorize a second “booster” dose of Johnson & Johnson’s JNJ, +0.74% COVID-19 vaccine for adults who were initially vaccinated with this vaccine, according to a group of scientists and clinicians that advises the regulator.
“This does look more like a two-dose vaccine,” Dr. Michael Nelson, a professor of medicine UVA Health and the UVA School of Medicine and a temporary voting member of the FDA committee.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
COVID-19 Live Updates: FDA to hold crunch talks over J&J and Moderna vaccine boostersThe Food and Drug Administration is set to hold crucial meetings over the next two days to decide whether to issue booster shots of Johnson & Johnson and Moderna COVID vaccines. Follow Newsweek's liveblog for all the latest.
Baca lebih lajut »
FDA vaccine advisers recommend emergency use authorization for booster dose of Moderna's Covid-19 vaccineVaccine advisers to the US Food and Drug Administration voted unanimously Thursday to recommend emergency use authorization of a booster dose of Moderna's Covid-19 vaccine.
Baca lebih lajut »
FDA Panel Votes to Recommend Moderna COVID-19 Booster ShotThe committee of experts followed their previous advice to recommend boosters of the Pfizer-BioNTech vaccine
Baca lebih lajut »
Abbott Labs unit recalling two COVID-19 lab test kits - FDAA unit of Abbott Laboratories is recalling two COVID-19 laboratory test kits as they can potentially issue false positive results, the U.S. Food and Drug Administration (FDA) said on Thursday.
Baca lebih lajut »
COVID-19 Live Updates: FDA to vote on Johnson & Johnson vaccine booster shot after Moderna approvedAn FDA expert panel will vote on whether to support or oppose a booster shot for the Johnson & Johnson COVID-19 vaccine. Follow Newsweek's liveblog for all the latest.
Baca lebih lajut »